Amplitude Surgical [AMPLI] vs Bonyf N.V [MLBON] Detailed Stock Comparison
Amplitude Surgical
Euronext
Loading...
Bonyf N.V
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Amplitude Surgical wins in 8 metrics, Bonyf N.V wins in 5 metrics, with 0 ties. Amplitude Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Amplitude Surgical | Bonyf N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 310.00 | N/A | N/A |
| Price-to-Book Ratio | 3.14 | 17.50 | Amplitude Surgical |
| Debt-to-Equity Ratio | 126.32 | 0.00 | Bonyf N.V |
| EV/EBITDA | 15.95 | 0.00 | Bonyf N.V |
| Profit Margin (TTM) | 1.00% | 8.02% | Bonyf N.V |
| Operating Margin (TTM) | 11.52% | -11.98% | Amplitude Surgical |
| EBITDA Margin (TTM) | 11.52% | N/A | N/A |
| Return on Equity | 1.15% | -1.38% | Amplitude Surgical |
| Return on Assets (TTM) | 3.10% | -1.09% | Amplitude Surgical |
| Free Cash Flow (TTM) | $-14.89M | $56.95M | Bonyf N.V |
| 1-Year Return | 97.45% | -19.38% | Amplitude Surgical |
| Price-to-Sales Ratio (TTM) | 2.74 | 27.60 | Amplitude Surgical |
| Enterprise Value | $397.58M | $0 | Amplitude Surgical |
| EV/Revenue Ratio | 3.67 | 0.00 | Bonyf N.V |
| Revenue per Share (TTM) | $2 | N/A | N/A |
| Earnings per Share (Diluted) | $0.02 | $-1.78 | Amplitude Surgical |
| Beta (Stock Volatility) | 0.13 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Amplitude Surgical vs Bonyf N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Amplitude Surgical | 0.00% | 0.00% | 1.64% | 0.81% | 83.43% | 93.75% |
| Bonyf N.V | 0.00% | 0.00% | 0.00% | -18.35% | -33.51% | -28.33% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Amplitude Surgical | 97.45% | 105.30% | 192.45% | 15.03% | 26.53% | 26.53% |
| Bonyf N.V | -19.38% | 7.50% | 3.20% | 3.20% | 3.20% | 3.20% |
Performance & Financial Health Analysis: Amplitude Surgical vs Bonyf N.V
| Metric | AMPLI | MLBON |
|---|---|---|
| Market Information | ||
| Market Cap | €297.45M | €7.77M |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 6,671 | 1 |
| 90 Day Avg. Volume | 6,761 | 0 |
| Last Close | €6.20 | €12.90 |
| 52 Week Range | €2.96 - €6.25 | €12.90 - €19.50 |
| % from 52W High | -0.80% | -33.85% |
| All-Time High | €6.25 (May 30, 2025) | €19.50 (Feb 17, 2025) |
| % from All-Time High | -0.80% | -33.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.08% |
| Operating Margin (TTM) | 0.12% | -0.12% |
| Return on Equity (TTM) | 0.01% | -0.01% |
| Debt to Equity (MRQ) | 126.32 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €1.97 | €0.74 |
| Cash per Share (MRQ) | €0.41 | N/A |
| Operating Cash Flow (TTM) | €5.93M | €56.95M |
| Levered Free Cash Flow (TTM) | €-11,550,125 | €-36,509 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Amplitude Surgical vs Bonyf N.V
| Metric | AMPLI | MLBON |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 310.00 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | 2.74 | 27.60 |
| Price to Book (MRQ) | 3.14 | 17.50 |
| Market Capitalization | ||
| Market Capitalization | €297.45M | €7.77M |
| Enterprise Value | €397.58M | €0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.67 | 0.00 |
| Enterprise to EBITDA | 15.95 | 0.00 |
| Risk & Other Metrics | ||
| Beta | 0.13 | N/A |
| Book Value per Share (MRQ) | €1.97 | €0.74 |
Financial Statements Comparison: Amplitude Surgical vs Bonyf N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMPLI | MLBON |
|---|---|---|
| Revenue/Sales | N/A | €789,432 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | €789,432 |
| EBITDA | N/A | €789,432 |
| Pre-Tax Income | N/A | €789,432 |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | €789,432 |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMPLI | MLBON |
|---|---|---|
| Cash & Equivalents | €29.10M | €16,301 |
| Total Current Assets | €94.65M | €1.42M |
| Total Current Liabilities | €46.91M | €287,755 |
| Long-Term Debt | €102.01M | €260,384 |
| Total Shareholders Equity | €95.82M | €433,967 |
| Retained Earnings | €1.53M | €144,167 |
| Property, Plant & Equipment | €50.75M | €13,146 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMPLI | MLBON |
|---|---|---|
| Operating Cash Flow | N/A | €236,514 |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | €236,514 |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMPLI | MLBON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 6,671 | 1 |
| Average Daily Volume (90 Day) | 6,761 | 0 |
| Shares Outstanding | 47.99M | 588,600 |
| Float Shares | 4.53M | N/A |
| % Held by Insiders | 0.91% | N/A |
| % Held by Institutions | 0.00% | N/A |
Dividend Analysis & Yield Comparison: Amplitude Surgical vs Bonyf N.V
| Metric | AMPLI | MLBON |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |